Baird Maintains Outperform on Medpace Holdings, Lowers Price Target to $477
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $565 to $477.
Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and lowers the price target from $565 to $477.